etoposide has been researched along with n-caproylsphingosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Boustany, RM; Guo, WX; Nikbakht, K; Puranam, KL; Qian, WH | 1 |
| Bernassola, F; Catani, MV; Corazzari, M; Green, DR; Melino, G; Rossi, A; Sabatini, S; Vilbois, F | 1 |
3 other study(ies) available for etoposide and n-caproylsphingosine
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide.
Topics: Apoptosis; Blotting, Western; Cell Division; Cell Line; Cell Survival; Cells, Cultured; Ceramides; Cyclins; Dose-Response Relationship, Drug; Etoposide; Humans; Membrane Glycoproteins; Models, Biological; Molecular Chaperones; Neurodegenerative Diseases; Poly(ADP-ribose) Polymerases; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae Proteins; Sphingosine; Staurosporine; Time Factors; Transfection; Vincristine | 1999 |
Nitric oxide inhibits apoptosis via AP-1-dependent CD95L transactivation.
Topics: Amino Acid Sequence; Apoptosis; Blotting, Western; Cell Nucleus; Ceramides; DNA Fragmentation; Dose-Response Relationship, Drug; Etoposide; Fas Ligand Protein; Humans; Jurkat Cells; Membrane Glycoproteins; Models, Biological; Molecular Sequence Data; Nitric Oxide; Nitric Oxide Donors; Nucleic Acid Synthesis Inhibitors; Penicillamine; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-jun; Time Factors; Transcription Factor AP-1; Transcriptional Activation; Transfection | 2000 |